Free Trial

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$3.15 -0.01 (-0.32%)
Closing price 04:00 PM Eastern
Extended Trading
$3.02 -0.13 (-4.10%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPID vs. ALNT, EYPT, LAB, SENS, CTKB, AEHR, QSI, QTRX, FEIM, and MASS

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Senseonics (SENS), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Frequency Electronics (FEIM), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

Rapid Micro Biosystems vs.

Allient (NASDAQ:ALNT) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, community ranking, risk, analyst recommendations and valuation.

61.6% of Allient shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 14.9% of Allient shares are owned by company insiders. Comparatively, 30.0% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Allient had 6 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 6 mentions for Allient and 0 mentions for Rapid Micro Biosystems. Allient's average media sentiment score of 1.15 beat Rapid Micro Biosystems' score of 0.00 indicating that Allient is being referred to more favorably in the media.

Company Overall Sentiment
Allient Positive
Rapid Micro Biosystems Neutral

Allient has higher revenue and earnings than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allient$516.06M1.01$24.10M$0.5952.08
Rapid Micro Biosystems$29.65M4.66-$52.47M-$1.03-3.06

Allient has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.

Allient has a net margin of 2.64% compared to Rapid Micro Biosystems' net margin of -184.93%. Allient's return on equity of 10.80% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Allient2.64% 10.80% 4.75%
Rapid Micro Biosystems -184.93%-48.05%-39.18%

Allient and Rapid Micro Biosystems both received 6 outperform votes by MarketBeat users. However, 54.55% of users gave Allient an outperform vote while only 35.29% of users gave Rapid Micro Biosystems an outperform vote.

CompanyUnderperformOutperform
AllientOutperform Votes
6
54.55%
Underperform Votes
5
45.45%
Rapid Micro BiosystemsOutperform Votes
6
35.29%
Underperform Votes
11
64.71%

Allient presently has a consensus target price of $31.00, indicating a potential upside of 0.88%. Rapid Micro Biosystems has a consensus target price of $8.00, indicating a potential upside of 153.57%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allient
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Rapid Micro Biosystems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

Allient beats Rapid Micro Biosystems on 13 of the 18 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$138.07M$4.32B$5.34B$8.44B
Dividend YieldN/A0.57%5.21%4.11%
P/E Ratio-2.8126.6826.9019.78
Price / Sales4.663.78389.48118.91
Price / CashN/A36.2438.2534.62
Price / Book1.131.546.784.52
Net Income-$52.47M-$84.30M$3.23B$248.23M
7 Day Performance3.10%3.70%2.02%0.81%
1 Month Performance37.17%5.29%10.97%13.32%
1 Year Performance276.04%-21.75%17.38%7.69%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
1.2772 of 5 stars
$3.15
-0.3%
$8.00
+154.0%
+272.9%$138.07M$29.65M-2.81200Gap Down
ALNT
Allient
2.6243 of 5 stars
$31.87
-1.0%
$31.00
-2.7%
+6.1%$539.53M$516.06M36.221,950Gap Up
EYPT
EyePoint Pharmaceuticals
2.4493 of 5 stars
$6.10
-0.5%
$25.38
+316.0%
-49.4%$419.75M$56.04M-3.05120Analyst Revision
Gap Up
LAB
Standard BioTools
2.3385 of 5 stars
$1.05
-2.8%
$2.50
+138.1%
-59.7%$398.81M$169.69M-1.48620Positive News
SENS
Senseonics
1.887 of 5 stars
$0.53
flat
$2.00
+277.4%
+6.4%$346.73M$23.68M-4.0890Gap Up
CTKB
Cytek Biosciences
2.0451 of 5 stars
$2.69
+0.7%
$5.25
+95.2%
-58.8%$340.71M$197.05M-33.62500News Coverage
Gap Up
AEHR
Aehr Test Systems
3.8929 of 5 stars
$9.04
-2.7%
$25.00
+176.5%
-26.3%$269.13M$61.48M12.0590Positive News
QSI
Quantum-Si
2.6192 of 5 stars
$1.41
-4.7%
$3.48
+146.5%
-14.7%$258.23M$3.06M-2.20150News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
Gap Up
QTRX
Quanterix
1.8292 of 5 stars
$4.87
+1.7%
$15.60
+220.3%
-71.3%$189.10M$133.92M-4.59460Positive News
Analyst Downgrade
Gap Up
FEIM
Frequency Electronics
2.5374 of 5 stars
$18.02
-0.7%
N/A+99.5%$174.38M$65.40M21.98200Positive News
MASS
908 Devices
2.8017 of 5 stars
$4.77
+4.1%
$5.33
+11.8%
-28.2%$171.06M$63.99M-2.6960Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners